�ݺ�ߣshows by User: GenesisCareUK

�ݺ�ߣshows by User: GenesisCareUK / http://www.slideshare.net/images/logo.gif �ݺ�ߣshows by User: GenesisCareUK / Tue, 25 Jul 2017 12:05:30 GMT �ݺ�ߣShare feed for �ݺ�ߣshows by User: GenesisCareUK Dupuytrens background info /slideshow/dupuytrens-background-info/78232323 dupuytrensbackgroundinfo-170725120530
What is Dupuytren’s Disease? • Benign thickening and shortening of the palmar fascia leading to digital contractures • Early phase with nodule and cord development, skin retraction • Late phase with formation of contracture Who gets Dupuytren’s disease? • Genetic predisposition – Especially in those of Northern European origin – Males > Females • Age – Wide range – Increases with age – Average age of onset 50 – 70 years • Occurrence – Common ]]>
What is Dupuytren’s Disease? • Benign thickening and shortening of the palmar fascia leading to digital contractures • Early phase with nodule and cord development, skin retraction • Late phase with formation of contracture Who gets Dupuytren’s disease? • Genetic predisposition – Especially in those of Northern European origin – Males > Females • Age – Wide range – Increases with age – Average age of onset 50 – 70 years • Occurrence – Common ]]> Tue, 25 Jul 2017 12:05:30 GMT /slideshow/dupuytrens-background-info/78232323 GenesisCareUK@slideshare.net(GenesisCareUK) Dupuytrens background info GenesisCareUK What is Dupuytren’s Disease? • Benign thickening and shortening of the palmar fascia leading to digital contractures • Early phase with nodule and cord development, skin retraction • Late phase with formation of contracture Who gets Dupuytren’s disease? • Genetic predisposition – Especially in those of Northern European origin – Males > Females • Age – Wide range – Increases with age – Average age of onset 50 – 70 years • Occurrence – Common <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/dupuytrensbackgroundinfo-170725120530-thumbnail.jpg?width=120&height=120&fit=bounds" /> What is Dupuytren’s Disease? • Benign thickening and shortening of the palmar fascia leading to digital contractures • Early phase with nodule and cord development, skin retraction • Late phase with formation of contracture Who gets Dupuytren’s disease? • Genetic predisposition – Especially in those of Northern European origin – Males > Females • Age – Wide range – Increases with age – Average age of onset 50 – 70 years • Occurrence – Common

Dupuytrens background info from GenesisCareUK

]]> 206 3 https://cdn.slidesharecdn.com/ss_thumbnails/dupuytrensbackgroundinfo-170725120530-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Georgina Grant - ActiFormCool /slideshow/georgina-grant-actiformcool/70059805 19georginagrant-actiformcoolfinal-161212150418
A proposed trial using ActiFormCool® as a prophylaxis to minimise radiation skin reaction for breast patients requiring full bolus.]]>
A proposed trial using ActiFormCool® as a prophylaxis to minimise radiation skin reaction for breast patients requiring full bolus.]]> Mon, 12 Dec 2016 15:04:18 GMT /slideshow/georgina-grant-actiformcool/70059805 GenesisCareUK@slideshare.net(GenesisCareUK) Georgina Grant - ActiFormCool GenesisCareUK A proposed trial using ActiFormCool® as a prophylaxis to minimise radiation skin reaction for breast patients requiring full bolus.� <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/19georginagrant-actiformcoolfinal-161212150418-thumbnail.jpg?width=120&height=120&fit=bounds" /> A proposed trial using ActiFormCool® as a prophylaxis to minimise radiation skin reaction for breast patients requiring full bolus.�

Georgina Grant - ActiFormCool from GenesisCareUK

]]> 420 7 https://cdn.slidesharecdn.com/ss_thumbnails/19georginagrant-actiformcoolfinal-161212150418-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Varian 360 Oncology and GenesisCare, Oxford /slideshow/varian-360-oncology-and-genesiscare-oxford/70059652 18sambennettccc-ukpresentationfinal-161212150153
Sam Bennett, GenesisCare, Oxford, presents their experience of Varian 360 Oncology in practice. ]]>
Sam Bennett, GenesisCare, Oxford, presents their experience of Varian 360 Oncology in practice. ]]> Mon, 12 Dec 2016 15:01:53 GMT /slideshow/varian-360-oncology-and-genesiscare-oxford/70059652 GenesisCareUK@slideshare.net(GenesisCareUK) Varian 360 Oncology and GenesisCare, Oxford GenesisCareUK Sam Bennett, GenesisCare, Oxford, presents their experience of Varian 360 Oncology in practice. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/18sambennettccc-ukpresentationfinal-161212150153-thumbnail.jpg?width=120&height=120&fit=bounds" /> Sam Bennett, GenesisCare, Oxford, presents their experience of Varian 360 Oncology in practice.

Varian 360 Oncology and GenesisCare, Oxford from GenesisCareUK

]]> 653 4 https://cdn.slidesharecdn.com/ss_thumbnails/18sambennettccc-ukpresentationfinal-161212150153-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Lauren Knight - Managing Increasing Patient Numbers with Decreased Time Slots /slideshow/lauren-knight-managing-increasing-patient-numbers-with-decreased-time-slots/70059402 14laurenknightfinal-161212145633
Discussion about how to treat more patients in less time, maintaining the highest quality. ]]>
Discussion about how to treat more patients in less time, maintaining the highest quality. ]]> Mon, 12 Dec 2016 14:56:33 GMT /slideshow/lauren-knight-managing-increasing-patient-numbers-with-decreased-time-slots/70059402 GenesisCareUK@slideshare.net(GenesisCareUK) Lauren Knight - Managing Increasing Patient Numbers with Decreased Time Slots GenesisCareUK Discussion about how to treat more patients in less time, maintaining the highest quality. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/14laurenknightfinal-161212145633-thumbnail.jpg?width=120&height=120&fit=bounds" /> Discussion about how to treat more patients in less time, maintaining the highest quality.

Lauren Knight - Managing Increasing Patient Numbers with Decreased Time Slots from GenesisCareUK

]]> 372 2 https://cdn.slidesharecdn.com/ss_thumbnails/14laurenknightfinal-161212145633-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Carlos Rodrigues, GenesisCare, International. /slideshow/carlos-rodrigues-genesiscare-international/70059313 13carlosrodriguesfinal-161212145419
Carlos Rodrigues from the international team in Spain, talks about radiotherapy efficiency whilst maintaining quality / access. ]]>
Carlos Rodrigues from the international team in Spain, talks about radiotherapy efficiency whilst maintaining quality / access. ]]> Mon, 12 Dec 2016 14:54:19 GMT /slideshow/carlos-rodrigues-genesiscare-international/70059313 GenesisCareUK@slideshare.net(GenesisCareUK) Carlos Rodrigues, GenesisCare, International. GenesisCareUK Carlos Rodrigues from the international team in Spain, talks about radiotherapy efficiency whilst maintaining quality / access. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/13carlosrodriguesfinal-161212145419-thumbnail.jpg?width=120&height=120&fit=bounds" /> Carlos Rodrigues from the international team in Spain, talks about radiotherapy efficiency whilst maintaining quality / access.

Carlos Rodrigues, GenesisCare, International. from GenesisCareUK

]]> 2193 8 https://cdn.slidesharecdn.com/ss_thumbnails/13carlosrodriguesfinal-161212145419-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Felix Navarro - Hyperthermia /slideshow/felix-navarro-hyperthermia/70059237 12felixnavarrohyperthermiafinal-161212145215
The effects of hyperthermia within oncology.]]>
The effects of hyperthermia within oncology.]]> Mon, 12 Dec 2016 14:52:15 GMT /slideshow/felix-navarro-hyperthermia/70059237 GenesisCareUK@slideshare.net(GenesisCareUK) Felix Navarro - Hyperthermia GenesisCareUK The effects of hyperthermia within oncology. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/12felixnavarrohyperthermiafinal-161212145215-thumbnail.jpg?width=120&height=120&fit=bounds" /> The effects of hyperthermia within oncology.

Felix Navarro - Hyperthermia from GenesisCareUK

]]> 764 3 https://cdn.slidesharecdn.com/ss_thumbnails/12felixnavarrohyperthermiafinal-161212145215-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Bernadette Lavery - Benefits of Protocol Standardisation and Evidence-Based Best Practice /GenesisCareUK/bernadette-lavery-benefits-of-protocol-standardisation-and-evidencebased-best-practice 11bernadettelaveryfinal-161212142219
Benefits of protocol standardisation and evidence-based best practice.]]>
Benefits of protocol standardisation and evidence-based best practice.]]> Mon, 12 Dec 2016 14:22:19 GMT /GenesisCareUK/bernadette-lavery-benefits-of-protocol-standardisation-and-evidencebased-best-practice GenesisCareUK@slideshare.net(GenesisCareUK) Bernadette Lavery - Benefits of Protocol Standardisation and Evidence-Based Best Practice GenesisCareUK Benefits of protocol standardisation and evidence-based best practice. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/11bernadettelaveryfinal-161212142219-thumbnail.jpg?width=120&height=120&fit=bounds" /> Benefits of protocol standardisation and evidence-based best practice.

Bernadette Lavery - Benefits of Protocol Standardisation and Evidence-Based Best Practice from GenesisCareUK

]]> 290 7 https://cdn.slidesharecdn.com/ss_thumbnails/11bernadettelaveryfinal-161212142219-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Jason Morton - SOP Linac Commissioning /slideshow/jason-morton-sop-linac-commissioning/70057538 9jasonmortonsoplinaccommissioninggccukfinal-161212140814
Commissioning using class solutions.]]>
Commissioning using class solutions.]]> Mon, 12 Dec 2016 14:08:13 GMT /slideshow/jason-morton-sop-linac-commissioning/70057538 GenesisCareUK@slideshare.net(GenesisCareUK) Jason Morton - SOP Linac Commissioning GenesisCareUK Commissioning using class solutions. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/9jasonmortonsoplinaccommissioninggccukfinal-161212140814-thumbnail.jpg?width=120&height=120&fit=bounds" /> Commissioning using class solutions.

Jason Morton - SOP Linac Commissioning from GenesisCareUK

]]> 467 2 https://cdn.slidesharecdn.com/ss_thumbnails/9jasonmortonsoplinaccommissioninggccukfinal-161212140814-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Professor Maria Hawkins - UK SABR Service Development Experiences /slideshow/professor-maria-hawkins-uk-sabr-service-development-experiences/70057348 8mariahawkinsfinal-161212140351
Stereotactic Body Radiation (SABR) principles, application, development and experiences.]]>
Stereotactic Body Radiation (SABR) principles, application, development and experiences.]]> Mon, 12 Dec 2016 14:03:51 GMT /slideshow/professor-maria-hawkins-uk-sabr-service-development-experiences/70057348 GenesisCareUK@slideshare.net(GenesisCareUK) Professor Maria Hawkins - UK SABR Service Development Experiences GenesisCareUK Stereotactic Body Radiation (SABR) principles, application, development and experiences. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/8mariahawkinsfinal-161212140351-thumbnail.jpg?width=120&height=120&fit=bounds" /> Stereotactic Body Radiation (SABR) principles, application, development and experiences.

Professor Maria Hawkins - UK SABR Service Development Experiences from GenesisCareUK

]]> 647 4 https://cdn.slidesharecdn.com/ss_thumbnails/8mariahawkinsfinal-161212140351-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Dr Vincent Khoo, CMO, GenesisCare - MRLinac /slideshow/dr-vincent-khoo-cmo-genesiscare-mrlinac/70056301 7vincentkhoomrlinacfinal-161212133505
MRLinac into the UK: Rationale and applications.]]>
MRLinac into the UK: Rationale and applications.]]> Mon, 12 Dec 2016 13:35:05 GMT /slideshow/dr-vincent-khoo-cmo-genesiscare-mrlinac/70056301 GenesisCareUK@slideshare.net(GenesisCareUK) Dr Vincent Khoo, CMO, GenesisCare - MRLinac GenesisCareUK MRLinac into the UK: Rationale and applications. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/7vincentkhoomrlinacfinal-161212133505-thumbnail.jpg?width=120&height=120&fit=bounds" /> MRLinac into the UK: Rationale and applications.

Dr Vincent Khoo, CMO, GenesisCare - MRLinac from GenesisCareUK

]]> 820 4 https://cdn.slidesharecdn.com/ss_thumbnails/7vincentkhoomrlinacfinal-161212133505-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Professor Mark Glaser (Imperial College London). Proton Therapy in the UK - Where are we? /slideshow/professor-mark-glaser-proton-therapy-in-the-uk/70056154 6profmarkglaserfinal-161212133056
A view of where we are with Proton Therapy in the UK today. ]]>
A view of where we are with Proton Therapy in the UK today. ]]> Mon, 12 Dec 2016 13:30:55 GMT /slideshow/professor-mark-glaser-proton-therapy-in-the-uk/70056154 GenesisCareUK@slideshare.net(GenesisCareUK) Professor Mark Glaser (Imperial College London). Proton Therapy in the UK - Where are we? GenesisCareUK A view of where we are with Proton Therapy in the UK today. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/6profmarkglaserfinal-161212133056-thumbnail.jpg?width=120&height=120&fit=bounds" /> A view of where we are with Proton Therapy in the UK today.

Professor Mark Glaser (Imperial College London). Proton Therapy in the UK - Where are we? from GenesisCareUK

]]> 811 5 https://cdn.slidesharecdn.com/ss_thumbnails/6profmarkglaserfinal-161212133056-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 A Collaborative Model for Continued Professional Development /slideshow/a-collaborative-model-for-continued-professional-development/70052270 5suzannecooperfinal-161212113944
Driving quality patient care through collaborative and continuous investment in CPD. ]]>
Driving quality patient care through collaborative and continuous investment in CPD. ]]> Mon, 12 Dec 2016 11:39:43 GMT /slideshow/a-collaborative-model-for-continued-professional-development/70052270 GenesisCareUK@slideshare.net(GenesisCareUK) A Collaborative Model for Continued Professional Development GenesisCareUK Driving quality patient care through collaborative and continuous investment in CPD. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/5suzannecooperfinal-161212113944-thumbnail.jpg?width=120&height=120&fit=bounds" /> Driving quality patient care through collaborative and continuous investment in CPD.

A Collaborative Model for Continued Professional Development from GenesisCareUK

]]> 395 6 https://cdn.slidesharecdn.com/ss_thumbnails/5suzannecooperfinal-161212113944-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Adaptive Radiotherapy at GenesisCare UK /slideshow/adaptive-radiotherapy-at-genesiscare-uk/70052116 4ajonesjdorneyadaptivetreatmentfinal-161212113405
A discussion about adaptive radiation therapy, a closed-loop radiation treatment process and how it can improve radiation treatment by systematically monitoring treatment variations and incorporating them to re-optimize the treatment plan early on during the course of treatment. ]]>
A discussion about adaptive radiation therapy, a closed-loop radiation treatment process and how it can improve radiation treatment by systematically monitoring treatment variations and incorporating them to re-optimize the treatment plan early on during the course of treatment. ]]> Mon, 12 Dec 2016 11:34:05 GMT /slideshow/adaptive-radiotherapy-at-genesiscare-uk/70052116 GenesisCareUK@slideshare.net(GenesisCareUK) Adaptive Radiotherapy at GenesisCare UK GenesisCareUK A discussion about adaptive radiation therapy, a closed-loop radiation treatment process and how it can improve radiation treatment by systematically monitoring treatment variations and incorporating them to re-optimize the treatment plan early on during the course of treatment. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/4ajonesjdorneyadaptivetreatmentfinal-161212113405-thumbnail.jpg?width=120&height=120&fit=bounds" /> A discussion about adaptive radiation therapy, a closed-loop radiation treatment process and how it can improve radiation treatment by systematically monitoring treatment variations and incorporating them to re-optimize the treatment plan early on during the course of treatment.

Adaptive Radiotherapy at GenesisCare UK from GenesisCareUK

]]> 708 4 https://cdn.slidesharecdn.com/ss_thumbnails/4ajonesjdorneyadaptivetreatmentfinal-161212113405-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Matt Hickey, Director of Clinical Strategy, - GenesisCare UK: Varian Medical Systems /slideshow/matt-hickey-director-of-clinical-strategy-genesiscare-uk-varian-medical-systems/70051994 3matthickeyfinal-161212112935
360 Oncology Cancer Care Coordination Suite: Collaborative Development Programme]]>
360 Oncology Cancer Care Coordination Suite: Collaborative Development Programme]]> Mon, 12 Dec 2016 11:29:35 GMT /slideshow/matt-hickey-director-of-clinical-strategy-genesiscare-uk-varian-medical-systems/70051994 GenesisCareUK@slideshare.net(GenesisCareUK) Matt Hickey, Director of Clinical Strategy, - GenesisCare UK: Varian Medical Systems GenesisCareUK 360 Oncology Cancer Care Coordination Suite: Collaborative Development Programme <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/3matthickeyfinal-161212112935-thumbnail.jpg?width=120&height=120&fit=bounds" /> 360 Oncology Cancer Care Coordination Suite: Collaborative Development Programme

Matt Hickey, Director of Clinical Strategy, - GenesisCare UK: Varian Medical Systems from GenesisCareUK

]]> 522 6 https://cdn.slidesharecdn.com/ss_thumbnails/3matthickeyfinal-161212112935-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Aldo Rolfo, National Clinical Development Manager, Genesis Cancer Care, Australia - Cancer Care Service of the Future /slideshow/aldo-rolfo-cancer-care-service-of-the-future/70051311 1aldorolfo-cancercaresof-161212110452
A program that seeks to redefine best practice across the drivers of the GenesisCare business (Quality, Access and Efficiency) in order to deliver on their vision of “Innovating Healthcare. Transforming Lives.” ]]>
A program that seeks to redefine best practice across the drivers of the GenesisCare business (Quality, Access and Efficiency) in order to deliver on their vision of “Innovating Healthcare. Transforming Lives.” ]]> Mon, 12 Dec 2016 11:04:52 GMT /slideshow/aldo-rolfo-cancer-care-service-of-the-future/70051311 GenesisCareUK@slideshare.net(GenesisCareUK) Aldo Rolfo, National Clinical Development Manager, Genesis Cancer Care, Australia - Cancer Care Service of the Future GenesisCareUK A program that seeks to redefine best practice across the drivers of the GenesisCare business (Quality, Access and Efficiency) in order to deliver on their vision of “Innovating Healthcare. Transforming Lives.” <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/1aldorolfo-cancercaresof-161212110452-thumbnail.jpg?width=120&height=120&fit=bounds" /> A program that seeks to redefine best practice across the drivers of the GenesisCare business (Quality, Access and Efficiency) in order to deliver on their vision of “Innovating Healthcare. Transforming Lives.”

Aldo Rolfo, National Clinical Development Manager, Genesis Cancer Care, Australia - Cancer Care Service of the Future from GenesisCareUK

]]> 1656 8 https://cdn.slidesharecdn.com/ss_thumbnails/1aldorolfo-cancercaresof-161212110452-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 https://public.slidesharecdn.com/v2/images/profile-picture.png https://cdn.slidesharecdn.com/ss_thumbnails/dupuytrensbackgroundinfo-170725120530-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/dupuytrens-background-info/78232323 Dupuytrens background ... https://cdn.slidesharecdn.com/ss_thumbnails/19georginagrant-actiformcoolfinal-161212150418-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/georgina-grant-actiformcool/70059805 Georgina Grant - ActiF... https://cdn.slidesharecdn.com/ss_thumbnails/18sambennettccc-ukpresentationfinal-161212150153-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/varian-360-oncology-and-genesiscare-oxford/70059652 Varian 360 Oncology an...